GT Healthcare Capital Partners: Funding, Team & Investors

Loading organizations...

GT Healthcare Capital Partners: Funding, Team & Investors | Startup Intros

Investment Activity

GT Healthcare Capital Partners has 13 tracked investments across 8 companies. The latest tracked deal is $55.0M Series B in Moon Surgical in May 2023.

Investments

8 companies

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 1, 2023	Moon Surgical	$55.0M Series B	Soffinova Partners, Mohamed (sid) Siddeek	99 Startups, Ascension Ventures, Cathay Health, Endeavor Venture Funds, Gradient Ventures, Nazca Ventures, NEW Enterprise Associates (NEA), Jenny Johnston, Sonder Capital, Colin Cahill, Maurice Ferre, Michael Shoemaker, Fred Moll, M.D, Josh Makower, Richard Leparmentier, Sacha Loiseau, Siddarth Satish, Yann Fleureau, Stephen Oesterle, Johnson & Johnson Innovation
May 1, 2023	Boundless Bio	$100.0M Series C	Fabio Pucci, RA Capital Management	ARCH Venture Partners, Nextech Invest, SignalFire, Versant Ventures, Alexandria Venture Investments, City Hill Ventures, Fidelity Management & Research Company, Logos Capital, Nextech Invest, PFM Health Sciences, Piper Heartland Healthcare Capital, Redmile Group, Sectoral Asset Management, Surveyor Capital, Vertex Ventures HC, Wellington Management
Apr 27, 2021	Exscientia	$225.0M Series D	SoftBank Vision Fund 2	BlackRock, Bristol Myers Squibb, Casdin Capital, Andrew Hopkins, Farallon Capital Management, Hongkou, Laurion Capital Management, Marshall Wace, Novo Holdings, Pivotal BioVenture Partners
Apr 1, 2021	Boundless Bio	$110.0M Series B	Jakob Loven, Zach Scheiner	ARCH Venture Partners, Nextech Invest, SignalFire, Versant Ventures, Alexandria Venture Investments, Boxer Capital, City Hill Ventures, Fidelity Management & Research Company, Logos Capital, PFM Health Sciences, Redmile Group, Surveyor Capital, Vertex Ventures HC, Wellington Management
Mar 4, 2021	Exscientia	$100.0M Series C	—	William Abecassis, Bristol Myers Squibb, Evotec, Novo Holdings
Aug 1, 2020	G.I. Windows	$16.0M Series A	—	Sonder Capital, John Cammett, Johnson & Johnson Innovation, Kennedy Trust
May 26, 2020	Exscientia	$60.0M Series C	Robert Ghenchev	Bristol Myers Squibb, Evotec
Feb 12, 2020	Oxford VR	$12.9M Series A	Ashish Patel	Isabel FOX, Oxford Science Enterprises, Oxford University
Sep 1, 2019	Boundless Bio	$46.0M Series A	ARCH Venture Partners, City Hill Ventures	Nextech Invest, RA Capital, SignalFire, Alexandria Venture Investments, Boxer Capital, Carolyn NG
Jan 7, 2019	Exscientia	$26.0M Series B	—	Celgene, Evotec
Jul 10, 2018	Potrero Medical	$26.6M Series C	GT Healthcare Capital Partners, Sonder Capital	—
May 1, 2018	Ultromics	$13.0M Series A	Oxford Science Enterprises	24Haymarket, Andre Crawford Brunt, Dieter Spälti, Muang Thai Fuchsia Ventures, Neptune, RT Ventures, Tanarra Capital
Apr 1, 2018	RefleXion Medical	$100.0M Series C	—	ALSA Ventures, Ascension Ventures, Soffinova Partners, Johnson & Johnson Innovation, KCK Group, T. Rowe Price Associates, Venrock